Australian biotech market today 28.04.09
Tuesday, 28 April, 2009
The healthcare indices are up a very healthy 2.6 per cent on the market at 3.00pm on a day when other shares lost yesterday’s gains.
Biota (ASX:BTA) is down a touch following its massive rise yesterday, when shares shot up 80 per cent. It has settled at a very respectable $1.50 today.
Investors obviously like the look of any stocks with a whiff of swine flu, as vaccine developer CSL (ASX:CLS) is up $1.15 to $33.
In terms of the other majors, Cochlear (ASX:COH) is up $1 while ResMed (ASX:RMD) is up 3c.
Hexima (ASX:HXL) is up 3c to 45c – see our profile of the agbiotech company, published today.
Alchemia (ASX:ACL) is almost 19 per cent, while Mesoblast (ASX:MSB) is down 4c to 73c.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
